A groundbreaking shift in our drug policy has taken place, as the authorities announce the availability of psilocybin fungi for therapeutic applications. Until now, these substances were strictly restricted, but a increasing body of evidence suggests they potentially offer benefits for psychological issues like depression. This change represents a